Cepheid downgraded to Neutral from Overweight at Piper Jaffray Piper Jaffray downgraded Cepheid on concerns the company's Q4 results and FY13 outlook could miss expectations. The firm lowered its price target for shares to $34 from $42.
News For CPHD From The Last 14 Days
Check below for free stories on CPHD the last two weeks.